GLP-1 Market Overview 2026 | Size, Share & Industry Trend 2034

Table of Contents

    1. Introduction
        1.1. Report Description
            1.1.1.  Objectives of the Study
            1.1.2.  Market Scope
            1.1.3.  Assumptions
        1.2. Stakeholders
    2. Executive Summary
        2.1. Market Highlights
    3. Research Methodology
        3.1. Overview
            3.1.1.  Data Mining
        3.2. Data Sources
            3.2.1.  Primary Sources
            3.2.2.  Secondary Sources
    4. Global GLP-1 Market Insights
        4.1. GLP-1 Market – Material Snapshot
        4.2. GLP-1 Market Dynamics
            4.2.1.  Drivers and Opportunities
                4.2.1.1. Rising prevalence of type 2 diabetes globally
                4.2.1.2. Increasing rates of obesity and related metabolic disorders
            4.2.2.  Restraints and Challenges
                4.2.2.1. High cost of GLP-1 drugs and affordability challenges
        4.3. Porter’s Five Forces Analysis
            4.3.1.  Bargaining Power of Suppliers (Moderate)
            4.3.2.  Threats of New Entrants: (Low)
            4.3.3.  Bargaining Power of Buyers (Moderate)
            4.3.4.  Threat of Substitute (Moderate)
            4.3.5.  Rivalry among existing firms (High)
        4.4. PESTEL Analysis
        4.5. GLP-1 Market Material Trends
        4.6. Value Chain Analysis
    5. Global GLP-1 Market, by Type of Molecule
        5.1. Key Findings
        5.2. Introduction
            5.2.1. Global GLP-1 Market, by Type of Molecule, 2021–2034 (USD Billion)
        5.3. Biologics
            5.3.1. Global GLP-1 Market, by Biologics, by Region, 2021–2034 (USD Billion)
        5.4. Small Molecules
            5.4.1. Global GLP-1 Market, by Small Molecules, by Region, 2021–2034 (USD Billion)
    6. Global GLP-1 Market, by Active Compound Used
        6.1. Key Findings
        6.2. Introduction
            6.2.1. Global GLP-1 Market, by Active Compound Used, 2021–2034 (USD Billion)
        6.3. Dulaglutide
            6.3.1. Global GLP-1 Market, by Dulaglutide, by Region, 2021–2034 (USD Billion)
        6.4. Liraglutide
            6.4.1. Global GLP-1 Market, by Liraglutide, by Region, 2021–2034 (USD Billion)
        6.5. Orforglipron
            6.5.1. Global GLP-1 Market, by Orforglipron, by Region, 2021–2034 (USD Billion)
        6.6. Retatrutide
            6.6.1. Global GLP-1 Market, by Retatrutide, by Region, 2021–2034 (USD Billion)
        6.7. Semaglutide
            6.7.1. Global GLP-1 Market, by Semaglutide, by Region, 2021–2034 (USD Billion)
        6.8. Survodutide
            6.8.1. Global GLP-1 Market, by Survodutide, by Region, 2021–2034 (USD Billion)
        6.9. Tirzepatide
            6.9.1. Global GLP-1 Market, by Tirzepatide, by Region, 2021–2034 (USD Billion)
        6.10. Other Active Compounds
            6.10.1. Global GLP-1 Market, by Other Active Compounds, by Region, 2021–2034 (USD Billion)
    7. Global GLP-1 Market, by Type of GLP-1 Agonist Drugs
        7.1. Key Findings
        7.2. Introduction
            7.2.1. Global GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
        7.3. Long-acting GLP-1 Agonist
            7.3.1. Global GLP-1 Market, by Long-acting GLP-1 Agonist, by Region, 2021-2034 (USD Billion)
        7.4. Short-acting GLP-1 Agonist
            7.4.1. Global GLP-1 Market, by Short-acting GLP-1 Agonist, by Region, 2021-2034 (USD Billion)
    8. Global GLP-1 Market, by Route of Administration
        8.1. Key Findings
        8.2. Introduction
            8.2.1. Global GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
        8.3. Oral
            8.3.1. Global GLP-1 Market, by Oral, by Region, 2021-2034 (USD Billion)
        8.4. Parenteral
            8.4.1. Global GLP-1 Market, by Parenteral, by Region, 2021-2034 (USD Billion)
    9. Global GLP-1 Market, by Target Indication
        9.1. Key Findings
        9.2. Introduction
            9.2.1. Global GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
        9.3. ALZHEIMER’S DISEASE
            9.3.1. Global GLP-1 Market, by ALZHEIMER’S DISEASE, 2021-2034 (USD Billion)
        9.4. Non-Alcoholic Steatohepatitis
            9.4.1. Global GLP-1 Market, by Non-Alcoholic Steatohepatitis, 2021-2034 (USD Billion)
        9.5. Obesity
            9.5.1. Global GLP-1 Market, by Obesity, 2021-2034 (USD Billion)
        9.6. Sleep Apnea
            9.6.1. Global GLP-1 Market, by Sleep Apnea, 2021-2034 (USD Billion)
        9.7. Type 2 Diabetes
            9.7.1. Global GLP-1 Market, by Type 2 Diabetes, 2021-2034 (USD Billion)
    10. Global GLP-1 Market, by Geography
        10.1. Key Findings
        10.2. Introduction
            10.2.1. GLP-1 Market Assessment, By Geography, 2021-2034 (USD Billion)
        10.3. GLP-1 Market – North America
            10.3.1. North America: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
            10.3.2. North America: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
            10.3.3. North America: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
            10.3.4. North America: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
            10.3.5. North America: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.3.6. GLP-1 Market – US
                10.3.6.1. US: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.3.6.2. US: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.3.6.3. US: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.3.6.4. US: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.3.6.5. US: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.3.7. GLP-1 Market – Canada
                10.3.7.1. Canada: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.3.7.2. Canada: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.3.7.3. Canada: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.3.7.4. Canada: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.3.7.5. Canada: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
        10.4. GLP-1 Market – Europe
            10.4.1. Europe: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
            10.4.2. Europe: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
            10.4.3. Europe: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
            10.4.4. Europe: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
            10.4.5. Europe: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.4.6. GLP-1 Market – UK
                10.4.6.1. UK: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.4.6.2. UK: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.4.6.3. UK: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.4.6.4. UK: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.4.6.5. UK: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.4.7. GLP-1 Market – France
                10.4.7.1. France: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.4.7.2. France: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.4.7.3. France: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.4.7.4. France: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.4.7.5. France: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.4.8. GLP-1 Market – Germany
                10.4.8.1. Germany: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.4.8.2. Germany: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.4.8.3. Germany: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.4.8.4. Germany: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.4.8.5. Germany: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.4.9. GLP-1 Market – Italy
                10.4.9.1. Italy: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.4.9.2. Italy: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.4.9.3. Italy: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.4.9.4. Italy: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.4.9.5. Italy: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.4.10. GLP-1 Market – Spain
                10.4.10.1. Spain: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.4.10.2. Spain: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.4.10.3. Spain: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.4.10.4. Spain: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.4.10.5. Spain: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.4.11. GLP-1 Market – Netherlands
                10.4.11.1. Netherlands: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.4.11.2. Netherlands: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.4.11.3. Netherlands: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.4.11.4. Netherlands: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.4.11.5. Netherlands: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.4.12. GLP-1 Market – Russia
                10.4.12.1. Russia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.4.12.2. Russia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.4.12.3. Russia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.4.12.4. Russia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.4.12.5. Russia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.4.13. GLP-1 Market – Rest of Europe
                10.4.13.1. Rest of Europe: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.4.13.2. Rest of Europe: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.4.13.3. Rest of Europe: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.4.13.4. Rest of Europe: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.4.13.5. Rest of Europe: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
        10.5. GLP-1 Market – Asia Pacific
            10.5.1. Asia Pacific: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
            10.5.2. Asia Pacific: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
            10.5.3. Asia Pacific: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
            10.5.4. Asia Pacific: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
            10.5.5. Asia Pacific: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.5.6. GLP-1 Market – China
                10.5.6.1. China: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.5.6.2. China: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.5.6.3. China: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.5.6.4. China: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.5.6.5. China: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.5.7. GLP-1 Market – India
                10.5.7.1. India: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.5.7.2. India: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.5.7.3. India: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.5.7.4. India: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.5.7.5. India: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.5.8. GLP-1 Market – Malaysia
                10.5.8.1. Malaysia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.5.8.2. Malaysia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.5.8.3. Malaysia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.5.8.4. Malaysia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.5.8.5. Malaysia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.5.9. GLP-1 Market – Japan
                10.5.9.1. Japan: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.5.9.2. Japan: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.5.9.3. Japan: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.5.9.4. Japan: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.5.9.5. Japan: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.5.10. GLP-1 Market – Indonesia
                10.5.10.1. Indonesia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.5.10.2. Indonesia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.5.10.3. Indonesia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.5.10.4. Indonesia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.5.10.5. Indonesia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.5.11. GLP-1 Market – South Korea
                10.5.11.1. South Korea: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.5.11.2. South Korea: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.5.11.3. South Korea: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.5.11.4. South Korea: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.5.11.5. South Korea: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.5.12. GLP-1 Market – Australia
                10.5.12.1. Australia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.5.12.2. Australia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.5.12.3. Australia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.5.12.4. Australia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.5.12.5. Australia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.5.13. GLP-1 Market – Rest of Asia Pacific
                10.5.13.1. Rest of Asia Pacific: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.5.13.2. Rest of Asia Pacific: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.5.13.3. Rest of Asia Pacific: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.5.13.4. Rest of Asia Pacific: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.5.13.5. Rest of Asia Pacific: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
        10.6. GLP-1 Market – Middle East & Africa
            10.6.1. Middle East & Africa: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
            10.6.2. Middle East & Africa: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
            10.6.3. Middle East & Africa: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
            10.6.4. Middle East & Africa: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
            10.6.5. Middle East & Africa: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.6.6. GLP-1 Market – Saudi Arabia
                10.6.6.1. Saudi Arabia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.6.6.2. Saudi Arabia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.6.6.3. Saudi Arabia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.6.6.4. Saudi Arabia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.6.6.5. Saudi Arabia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.6.7. GLP-1 Market – UAE
                10.6.7.1. UAE: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.6.7.2. UAE: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.6.7.3. UAE: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.6.7.4. UAE: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.6.7.5. UAE: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.6.8. GLP-1 Market – Israel
                10.6.8.1. Israel: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.6.8.2. Israel: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.6.8.3. Israel: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.6.8.4. Israel: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.6.8.5. Israel: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.6.9. GLP-1 Market – South Africa
                10.6.9.1. South Africa: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.6.9.2. South Africa: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.6.9.3. South Africa: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.6.9.4. South Africa: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.6.9.5. South Africa: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.6.10. GLP-1 Market – Rest of Middle East & Africa
                10.6.10.1. Rest of Middle East & Africa: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.6.10.2. Rest of Middle East & Africa: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.6.10.3. Rest of Middle East & Africa: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.6.10.4. Rest of Middle East & Africa: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.6.10.5. Rest of Middle East & Africa: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
        10.7. GLP-1 Market – Latin America
            10.7.1. Latin America: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
            10.7.2. Latin America: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
            10.7.3. Latin America: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
            10.7.4. Latin America: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
            10.7.5. Latin America: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.7.6. GLP-1 Market – Mexico
                10.7.6.1. Mexico: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.7.6.2. Mexico: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.7.6.3. Mexico: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.7.6.4. Mexico: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.7.6.5. Mexico: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.7.7. GLP-1 Market – Brazil
                10.7.7.1. Brazil: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.7.7.2. Brazil: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.7.7.3. Brazil: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.7.7.4. Brazil: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.7.7.5. Brazil: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.7.8. GLP-1 Market – Argentina
                10.7.8.1. Argentina: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.7.8.2. Argentina: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.7.8.3. Argentina: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.7.8.4. Argentina: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.7.8.5. Argentina: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
            10.7.9. GLP-1 Market – Rest of Latin America
                10.7.9.1. Rest of Latin America: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
                10.7.9.2. Rest of Latin America: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
                10.7.9.3. Rest of Latin America: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
                10.7.9.4. Rest of Latin America: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
                10.7.9.5. Rest of Latin America: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    11. Competitive Landscape
        11.1. Expansion and Acquisition Analysis
            11.1.1. Expansion
            11.1.2. Acquisitions
        11.2. Partnerships/Collaborations/Agreements/Exhibitions
    12. Company Profiles
        12.1. AstraZeneca
            12.1.1. Company Overview
            12.1.2. Financial Performance
            12.1.3. Product Benchmarking
            12.1.4. Recent Development
        12.2. Boehringer Ingelheim
            12.2.1. Company Overview
            12.2.2. Financial Performance
            12.2.3. Product Benchmarking
            12.2.4. Recent Development
        12.3. D&D Pharmatech
            12.3.1. Company Overview
            12.3.2. Financial Performance
            12.3.3. Product Benchmarking
            12.3.4. Recent Development
        12.4. Eli Lilly
            12.4.1. Company Overview
            12.4.2. Financial Performance
            12.4.3. Product Benchmarking
            12.4.4. Recent Development
        12.5. Hanmi Pharmaceutical
            12.5.1. Company Overview
            12.5.2. Financial Performance
            12.5.3. Product Benchmarking
            12.5.4. Recent Development
        12.6. Novo Nordisk
            12.6.1. Company Overview
            12.6.2. Financial Performance
            12.6.3. Product Benchmarking
            12.6.4. Recent Development
        12.7. Pfizer
            12.7.1. Company Overview
            12.7.2. Financial Performance
            12.7.3. Product Benchmarking
            12.7.4. Recent Development
        12.8. Roche
            12.8.1. Company Overview
            12.8.2. Financial Performance
            12.8.3. Product Benchmarking
            12.8.4. Recent Development
        12.9. Sanofi
            12.9.1. Company Overview
            12.9.2. Financial Performance
            12.9.3. Product Benchmarking
            12.9.4. Recent Development
        12.10. Tonghua Dongbao Pharmaceutical
            12.10.1. Company Overview
            12.10.2. Financial Performance
            12.10.3. Product Benchmarking
            12.10.4. Recent Development

    List of Tables:

    Table 1 Global GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 2 Global GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 3 Global GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 4 Global GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 5 Global GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 6 North America: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 7 North America: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 8 North America: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 9 North America: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 10 North America: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 11 US: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 12 US: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 13 US: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 14 US: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 15 US: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 16 Canada: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 17 Canada: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 18 Canada: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 19 Canada: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 20 Canada: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 21 Europe: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 22 Europe: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 23 Europe: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 24 Europe: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 25 Europe: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 26 UK: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 27 UK: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 28 UK: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 29 UK: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 30 UK: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 31 France: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 32 France: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 33 France: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 34 France: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 35 France: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 36 Germany: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 37 Germany: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 38 Germany: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 39 Germany: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 40 Germany: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 41 Italy: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 42 Italy: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 43 Italy: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 44 Italy: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 45 Italy: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 46 Spain: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 47 Spain: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 48 Spain: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 49 Spain: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 50 Spain: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 51 Netherlands: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 52 Netherlands: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 53 Netherlands: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 54 Netherlands: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 55 Netherlands: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 56 Russia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 57 Russia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 58 Russia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 59 Russia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 60 Russia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 61 Rest of Europe: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 62 Rest of Europe: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 63 Rest of Europe: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 64 Rest of Europe: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 65 Rest of Europe: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 66 Asia Pacific: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 67 Asia Pacific: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 68 Asia Pacific: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 69 Asia Pacific: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 70 Asia Pacific: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 71 China: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 72 China: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 73 China: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 74 China: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 75 China: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 76 India: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 77 India: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 78 India: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 79 India: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 80 India: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 81 Malaysia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 82 Malaysia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 83 Malaysia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 84 Malaysia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 85 Malaysia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 86 Japan: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 87 Japan: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 88 Japan: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 89 Japan: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 90 Japan: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 91 Indonesia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 92 Indonesia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 93 Indonesia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 94 Indonesia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 95 Indonesia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 96 South Korea: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 97 South Korea: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 98 South Korea: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 99 South Korea: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 100 South Korea: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 101 Australia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 102 Australia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 103 Australia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 104 Australia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 105 Australia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 106 Rest of Asia Pacific: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 107 Rest of Asia Pacific: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 108 Rest of Asia Pacific: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 109 Rest of Asia Pacific: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 110 Rest of Asia Pacific: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 111 Middle East & Africa: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 112 Middle East & Africa: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 113 Middle East & Africa: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 114 Middle East & Africa: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 115 Middle East & Africa: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 116 Saudi Arabia: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 117 Saudi Arabia: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 118 Saudi Arabia: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 119 Saudi Arabia: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 120 Saudi Arabia: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 121 UAE: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 122 UAE: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 123 UAE: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 124 UAE: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 125 UAE: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 126 Israel: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 127 Israel: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 128 Israel: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 129 Israel: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 130 Israel: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 131 South Africa: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 132 South Africa: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 133 South Africa: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 134 South Africa: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 135 South Africa: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 136 Rest of Middle East & Africa: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 137 Rest of Middle East & Africa: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 138 Rest of Middle East & Africa: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 139 Rest of Middle East & Africa: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 140 Rest of Middle East & Africa: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 141 Latin America: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 142 Latin America: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 143 Latin America: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 144 Latin America: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 145 Latin America: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 146 Mexico: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 147 Mexico: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 148 Mexico: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 149 Mexico: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 150 Mexico: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 151 Brazil: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 152 Brazil: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 153 Brazil: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 154 Brazil: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 155 Brazil: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 156 Argentina: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 157 Argentina: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 158 Argentina: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 159 Argentina: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 160 Argentina: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)
    Table 161 Rest of Latin America: GLP-1 Market, By Type of Molecule, 2021-2034 (USD Billion)
    Table 162 Rest of Latin America: GLP-1 Market, By Active Compound Used, 2021-2034 (USD Billion)
    Table 163 Rest of Latin America: GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2021-2034 (USD Billion)
    Table 164 Rest of Latin America: GLP-1 Market, by Route of Administration, 2021-2034 (USD Billion)
    Table 165 Rest of Latin America: GLP-1 Market, by Target Indication, 2021-2034 (USD Billion)

    List of Figures:

    Figure 1. Global GLP-1 Market, 2021-2034 (USD Billion)
    Figure 2. Integrated Ecosystem
    Figure 3. Research Methodology: Top-Down & Bottom-Up Price
    Figure 4. Market by Geography
    Figure 5. Porter’s Five Forces
    Figure 6. Market By Type of Molecule
    Figure 7. Global GLP-1 Market, By Type of Molecule, 2025 & 2034 (USD Billion)
    Figure 8. Market By Active Compound Used
    Figure 9. Global GLP-1 Market, By Active Compound Used, 2025 & 2034 (USD Billion)
    Figure 10. Market by Type of GLP-1 Agonist Drugs
    Figure 11. Global GLP-1 Market, by Type of GLP-1 Agonist Drugs, 2025 & 2034 (USD Billion)
    Figure 12. Market by Route of Administration
    Figure 13. Global GLP-1 Market, by Route of Administration, 2025 & 2034 (USD Billion)
    Figure 14. Market by Target Indication
    Figure 15. Global GLP-1 Market, by Target Indication, 2025 & 2034 (USD Billion)